2020
Impact of the COVID‐19 pandemic on telehealth research in cancer prevention and care: A call to sustain telehealth advances
Park ER, Chiles C, Cinciripini PM, Foley KL, Fucito LM, Haas JS, Joseph AM, Ostroff JS, Rigotti NA, Shelley DR, Taylor KL, Zeliadt SB, Toll BA, Group T. Impact of the COVID‐19 pandemic on telehealth research in cancer prevention and care: A call to sustain telehealth advances. Cancer 2020, 127: 334-338. PMID: 33048350, PMCID: PMC7675475, DOI: 10.1002/cncr.33227.Peer-Reviewed Original ResearchMeSH KeywordsBiomedical ResearchConfidentialityCOVID-19Delivery of Health CareHumansLungLung NeoplasmsNeoplasmsPatient ParticipationSmoking CessationTelemedicineTomography, X-Ray Computed
2016
Pairing smoking‐cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
Fucito LM, Czabafy S, Hendricks PS, Kotsen C, Richardson D, Toll BA, Committee F. Pairing smoking‐cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer 2016, 122: 1150-1159. PMID: 26916412, PMCID: PMC4828323, DOI: 10.1002/cncr.29926.Peer-Reviewed Original ResearchConceptsLung cancer screeningSmoking cessation interventionUS Preventive Services Task ForceLow-dose computed tomographyCancer screeningSmoking cessationTobacco useEvidence-based smoking cessation interventionsAge 55Evidence-based smoking cessation treatmentLung cancer screening participantsAnnual lung cancerPatients age 55Pack-year historySmoking cessation effortsSmoking cessation servicesSmoking cessation treatmentHigh-risk groupEvidence-based treatmentsEvidence-based behavioral strategiesScreening participantsLung cancerClinical guidelinesClinical recommendationsPremature mortality